The Investor
21 Apr 2026, 16:07
Merck announced the launch of the first bio-based solvent portfolio for high-performance liquid chromatography (HPLC), aimed at reducing environmental impact while maintaining analytical performance. The new solvents are produced from renewable feedstocks and deliver on average 25.9% lower carbon emissions compared to conventional fossil-based alternatives.
Designed as drop-in replacements for commonly used solvents such as acetonitrile, methanol, and ethanol, the products allow laboratories to transition without modifying existing analytical methods. The company said this ensures seamless adoption in applications including drug development, quality control, environmental testing, and diagnostics.
Merck emphasized that the innovation supports its broader sustainability strategy by helping customers reduce greenhouse gas emissions without compromising precision or reliability in laboratory workflows.
Designed as drop-in replacements for commonly used solvents such as acetonitrile, methanol, and ethanol, the products allow laboratories to transition without modifying existing analytical methods. The company said this ensures seamless adoption in applications including drug development, quality control, environmental testing, and diagnostics.
Merck emphasized that the innovation supports its broader sustainability strategy by helping customers reduce greenhouse gas emissions without compromising precision or reliability in laboratory workflows.